[Federal Register Volume 72, Number 221 (Friday, November 16, 2007)]
[Notices]
[Pages 64655-64656]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 07-5677]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Cancer Institute; Notice of Closed Meetings

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended (5 U.S.C. Appendix 2), notice is hereby given of the following 
meetings.
    The meetings will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 
U.S.C., as amended. The grant applications and the discussions could 
disclose confidential trade secrets or commercial property such as 
patentable material, and personal information concerning individuals 
associated with the grant applications, the disclosure of which would 
constitute a clearly unwarranted invasion of personal privacy.

    Name of Committee: National Cancer Institute Initial Review 
Group; Subcommittee A--Cancer Centers.
    Date: December 6-7, 2007.
    Time: 8 a.m. to 11 a.m.
    Agenda: To review and evaluate grant applications.
    Place: Doubletree Hotel Bethesda, 8120 Wisconsin Avenue, 
Bethesda, MD 20814.
    Contact Person: Gail J. Bryant, MD, Scientific Review 
Administrator, Grants Review Branch, Division of Extramural 
Activities, National Cancer Institute, National Institutes of 
Health, 6116 Executive Boulevard, Room 8042, Bethesda, MD 20852-
7405, (301) 402-0801.

    Name of Committee: National Cancer Institute Special Panel; 
Cancer Center Support Grant.
    Dated: December 6, 2007
    Time: 2:40 p.m. to 5 p.m.
    Agenda: To review and evaluate grant applications.
    Place: Double Tree Bethesda, 8120 Wisconsin Avenue, Bethesda, MD 
20814.
    Contact Person: David E. Maslow, PhD, Chief, Resources and 
Training Review Branch, Division of Extramural Activities, National 
Cancer Institute, National Institutes of Health, 6116 Executive 
Boulevard--Room 8117, Bethesda, MD 20892-7405, (301) 496-2330.

    Name of Committee: National Cancer Institute Special Emphasis 
Panel; Prevention, Control and Population Sciences.
    Date: January 30-31, 2008.
    Time: 8 a.m. to 5 p.m.
    Agenda: To review and evaluate grant applications.
    Place: Courtyard Gaithersburg Washingtonian Center, 204 
Boardwalk Place, Gaithersburg, MD 20878.
    Contact Person: Wlodek Lopaczynski, MD, PhD, Scientific Review 
Administrator, Research Programs Review Branch, Division of 
Extramural Activities, National Cancer Institute, 6116 Executive 
Blvd. Room 8131, Bethesda, MD 20892, 301-594-1402, 
<a href="/cdn-cgi/l/email-protection#076b6877666470476a666e6b29696e6f29606871"><span class="__cf_email__" data-cfemail="82eeedf2e3e1f5c2efe3ebeeacecebeaace5edf4">[email protected]</span></a>.

    Name of Committee: National Cancer Institute Special Emphasis 
Panel; Molecular Oncology.
    Date: February 6-8, 2008.
    Time: 5:30 p.m. to 3 p.m.
    Agenda: To review and evaluate grant applications.
    Place: Hyatt Regency Bethesda, One Bethesda Metro Center, 7400 
Wisconsin Avenue, Bethesda, MD 20814.
    Contact Person: Michael B. Small, PhD, Scientific Review 
Administrator, Division of Extramural Activities, National Cancer 
Institute, National Institutes of Health, 6116 Executive Blvd., Room 
8127, Bethesda, MD 20892-8328, 301-402-0996, <a href="/cdn-cgi/l/email-protection#651608040909082508040c094b0b0c0d4b020a13"><span class="__cf_email__" data-cfemail="384b5559545455785559515416565150165f574e">[email protected]</span></a>.

    Name of Committee: National Cancer Institute Special Emphasis 
Panel; SPORE in Lymphoma, Myeloma, Pancreas, GI, H&N and Lung 
Cancers.
    Date: February 12-14, 2008.
    Time: February 12, 2008, 8 a.m. to 1 p.m.
    Agenda: To review and evaluate grant applications.
    Place: Marriott Bethesda, 5151 Pooks Hill Rd., Bethesda, MD 
20814.
    Contact Person: Shamala K. Srinivas, PhD, Scientific Review 
Administrator, Research Programs Review Branch, Division of 
Extramural Activities, National Cancer Institute, National 
Institutes of Health, 6116 Executive Boulevard, Room 8123, Bethesda, 
MD 20892, 301-594-1224, <a href="/cdn-cgi/l/email-protection#5b28286e686c2f1b353233753c342d"><span class="__cf_email__" data-cfemail="cfbcbcfafcf8bb8fa1a6a7e1a8a0b9">[email protected]</span></a>.

    Name of Committee: National Cancer Institute Special Emphasis 
Panel; SPORE in Breast, Gynecologic, Genitourinary and Prostate 
Cancers.
    Date: February 12-14, 2008.
    Time: 8 a.m. to 5 p.m.
    Agenda: To review and evaluate grant applications.
    Place: Bethesda Marriott, 5151 Pooks Hill Road, Bethesda, MD 
20814.
    Contact Person: Caron Lyman, PhD, Scientific Review 
Administrator, Division of Extramural Activities, National Cancer 
Institute, National Institutes of Health, 6116 Executive Blvd., Room 
8119, Bethesda, MD 20892-8328, 301-451-4761, <a href="/cdn-cgi/l/email-protection#701c091d111e13301d11191c5e1e19185e171f06"><span class="__cf_email__" data-cfemail="b3dfcaded2ddd0f3ded2dadf9ddddadb9dd4dcc5">[email protected]</span></a>.

    Name of Committee: National Cancer Institute Special Emphasis 
Panel; Application of Emerging Technologies for Cancer Research.
    Date: March 19-20, 2008.
    Time: 8 a.m. to 5 p.m.
    Agenda: To review and evaluate grant applications.
    Place: Bethesda Marriott Suites, 6711 Democracy Boulevard, 
Bethesda, MD 20817.
    Contact Person: Marvin L. Salin, PhD, Scientific Review 
Administrator, Special

[[Page 64656]]

Review and Logistics Branch, Division of Extramural Activities, 
National Cancer Institute, 6116 Executive Boulevard, Room 7073, 
Bethesda, MD 20892-8329, 301-496-0694, <a href="/cdn-cgi/l/email-protection#a3ced0c2cfcacde3cec2cacf8dcdcacb8dc4ccd5"><span class="__cf_email__" data-cfemail="04697765686d6a4469656d682a6a6d6c2a636b72">[email protected]</span></a>.

(Catalogue of Federal Domestic Assistance Program Nos. 93.392, 
Cancer Construction; 93.393, Cancer Cause and Prevention Research; 
93.394, Cancer Detection and Diagnosis Research; 93.395, Cancer 
Treatment Research; 93.396, Cancer Biology Research; 93.397, Cancer 
Centers Support; 93.398, Cancer Research Manpower, 93.399, Cancer 
Control, National Institutes of Health, HHS)

    Dated: November 7, 2007.
Jennifer Spaeth,
Director, Office of Federal Advisory Committee Policy.
[FR Doc. 07-5677 Filed 11-15-07; 8:45 am]
BILLING CODE 4140-01-M


</pre><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script></body>
</html>